Total Payments
$2,130
2020 Payments
$70.00
Companies
31
Transactions
149
Medicare Patients
4,788
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$2,117 (99.4%)
Education$12.95 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,117 | 147 | 99.4% |
| Education | $12.95 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $319.22 | 26 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $309.74 | 20 | $0 (2020) |
| PFIZER INC. | $301.06 | 20 | $0 (2019) |
| Novo Nordisk Inc | $266.39 | 22 | $0 (2019) |
| Lilly USA, LLC | $174.17 | 11 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $131.30 | 9 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $68.68 | 4 | $0 (2019) |
| Shire North American Group Inc | $58.81 | 4 | $0 (2018) |
| SANOFI PASTEUR INC. | $46.14 | 3 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $46.01 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $70.00 | 4 | Allergan, Inc. ($21.76) |
| 2019 | $648.27 | 44 | AstraZeneca Pharmaceuticals LP ($198.31) |
| 2018 | $649.85 | 46 | PFIZER INC. ($123.67) |
| 2017 | $761.76 | 55 | Novo Nordisk Inc ($139.58) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/19/2020 | iRhythm Technologies, Inc. | ZIO Patch (Device) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/08/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/23/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY XR | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: DIABETES | ||||||
| 12/03/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/02/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/20/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: GASTROINTESTINAL | ||||||
| 11/20/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2019 | iRhythm Technologies, Inc. | ZIO Patch (Device) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/26/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: DIABETES | ||||||
| 10/23/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 10/22/2019 | SANOFI PASTEUR INC. | ADACEL (Drug), FLUBLOK QUADRIVALENT, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: VACCINES | ||||||
| 10/16/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Diabetes | ||||||
| 10/16/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Diabetes | ||||||
| 10/15/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Diabetes | ||||||
| 09/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/05/2019 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: ADHD | ||||||
| 09/04/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Diabetes | ||||||
| 08/21/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: KRYSTEXXA | ||||||
| 08/20/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/01/2019 | Glenmark Therapeutics Inc. | Ecoza (Drug) | Food and Beverage | Cash or cash equivalent | $13.00 | General |
| Category: AntiFungal | ||||||
| 07/26/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,458 | 3,433 | $804,231 | $316,434 |
| 2022 | 13 | 1,129 | 2,684 | $788,276 | $319,269 |
| 2021 | 12 | 1,084 | 2,906 | $839,290 | $416,328 |
| 2020 | 12 | 1,117 | 2,909 | $806,601 | $351,791 |
Total Patients
4,788
Total Services
11,932
Medicare Billing
$1.4M
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 382 | 1,285 | $357,230 | $129,556 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 257 | 697 | $229,313 | $104,888 | 45.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 211 | 211 | $63,300 | $30,719 | 48.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 25 | 30 | $15,000 | $7,573 | 50.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 32 | 32 | $16,512 | $6,686 | 40.5% |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | Office | 2023 | 64 | 560 | $28,000 | $6,586 | 23.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 57 | 57 | $29,412 | $6,506 | 22.1% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 40 | 40 | $12,000 | $4,318 | 36.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $5,520 | $3,338 | 60.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 31 | 86 | $8,600 | $3,043 | 35.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 40 | 62 | $6,200 | $2,737 | 44.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 31 | 50 | $5,000 | $2,400 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 30 | $6,210 | $2,034 | 32.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,540 | $2,011 | 56.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 137 | 155 | $9,920 | $1,936 | 19.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 62 | 63 | $6,174 | $1,254 | 20.3% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 31 | 46 | $2,300 | $850.54 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 433 | 1,707 | $474,546 | $178,187 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 212 | 485 | $159,560 | $77,823 | 48.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 194 | 194 | $58,320 | $29,361 | 50.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 69 | 69 | $35,604 | $8,091 | 22.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 21 | 25 | $12,500 | $6,550 | 52.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 20 | 20 | $10,320 | $4,210 | 40.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 18 | 18 | $6,912 | $2,997 | 43.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $4,812 | $2,887 | 60.0% |
About Dr. David Plotkin, M.D
Dr. David Plotkin, M.D is a Sports Medicine healthcare provider based in Olney, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831265685.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Plotkin, M.D has received a total of $2,130 in payments from pharmaceutical and medical device companies, with $70.00 received in 2020. These payments were reported across 149 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,117).
As a Medicare-enrolled provider, Plotkin has provided services to 4,788 Medicare beneficiaries, totaling 11,932 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Other Specialties Sleep Medicine, Sports Medicine
- Location Olney, MD
- Active Since 11/24/2006
- Last Updated 01/29/2022
- Taxonomy Code 207RS0010X
- Entity Type Individual
- NPI Number 1831265685
Products in Payments
- FARXIGA (Drug) $309.74
- JANUVIA (Drug) $195.52
- Victoza (Drug) $154.94
- TRULICITY (Drug) $129.63
- CHANTIX (Drug) $127.08
- JARDIANCE (Drug) $72.17
- XARELTO (Drug) $68.68
- TRADJENTA (Drug) $67.78
- VIAGRA (Drug) $66.16
- CYCLOSET (Drug) $64.42
- ASMANEX (Drug) $52.19
- TOVIAZ (Drug) $47.19
- UNITHROID (Drug) $41.85
- SHINGRIX (Biological) $40.07
- Ozempic (Drug) $37.64
- Tresiba (Drug) $34.79
- FLUZONE HIGH-DOSE (Drug) $33.64
- MYDAYIS (Drug) $30.58
- Prolia (Biological) $29.39
- SOLIQUA (Drug) $29.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.